Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MAIA Biotechnology, Inc.MAIA · Entity 6919 | Director | September 30, 2026 | October 03, 2026 |
| TransUnionTRU · Entity 2287 | President, US Markets | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MAIA Biotechnology, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.18 · Expires 2036-09-30 | Direct | 32,774 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 32,774 · Balance 32,774 F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
TransUnion
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,888 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Sale · Disposed 1,000 · Balance 79,888 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:14 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 32,774 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001878313-26-000095 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,774 Underlying: Common Stock · 32,774 shares Expires 2036-09-30 F1 · derivative.exercise_date: The stock options, granted on September 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:57 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $84.42 | $84,420.00 |
DisclosureSEC source: 0001776865-26-000024 · wk-form4_1788472638.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,888 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 21:57 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 8,018 | $85.67 | $686,902.06 |
DisclosureSEC source: 0001776865-26-000022 · wk-form4_1788299871.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,888 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 28, 2023, February 28, 2024 and February 28, 2025. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 23:54 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $79.96 | $79,960.00 |
DisclosureSEC source: 0001776865-26-000020 · wk-form4_1785887673.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,906 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:35 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 10,000 | $72.64 | $726,400.00 |
DisclosureSEC source: 0001776865-26-000018 · wk-form4_1783024531.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,906 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:15 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 26,982 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001878313-26-000074 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,982 Underlying: Common Stock · 26,982 shares Expires 2036-06-30 F1 · derivative.exercise_date: The stock options, granted on June 30, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 22:58 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 5,000 | $70.73 | $353,650.00 |
DisclosureSEC source: 0001776865-26-000016 · wk-form4_1780527512.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,906 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 18, 2026 Filed May 19, 2026 21:15 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 16,063 | $68.60 | $1,101,921.80 |
DisclosureSEC source: 0001776865-26-000014 · wk-form4_1779225348.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,906 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of performance share units granted on June 1, 2023. Read SEC document |
| May 12, 2026 Filed May 14, 2026 22:30 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 36,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-26-000012 · wk-form4_1778797857.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,969 F1 · kind: Reflects shares of Common Stock earned upon the attainment of certain performance goals set forth in an award agreement for performance share units granted on June 1, 2023. Read SEC document |
| May 01, 2026 Filed May 4, 2026 23:11 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 5,000 | $71.93 | $359,650.00 |
DisclosureSEC source: 0001776865-26-000010 · wk-form4_1777936308.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,711 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 21:00 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 5,000 | $70.00 | $350,000.00 |
DisclosureSEC source: 0001776865-26-000008 · wk-form4_1775509245.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,711 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:56 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 27,907 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001878313-26-000039 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,907 Underlying: Common Stock · 27,907 shares Expires 2036-03-31 F1 · derivative.exercise_date: The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:13 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 5,000 | $76.64 | $383,200.00 |
DisclosureSEC source: 0001776865-26-000006 · wk-form4_1772575987.xml · nonDerivative · entry 3 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,711 F3 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 22:13 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 10,627 | $78.55 | $834,750.85 |
DisclosureSEC source: 0001776865-26-000006 · wk-form4_1772575987.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,711 F2 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of performance share units granted on February 28, 2023. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 22:13 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 24,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-26-000006 · wk-form4_1772575987.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,338 F1 · kind: Represents a grant of restricted stock units that vest ratably as follows: 33% on August 27, 2027; 33% on August 27, 2028; and 34% on August 27, 2029. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 23:05 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 23,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-26-000004 · wk-form4_1770937503.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,513 F1 · kind: Reflects shares of Common Stock earned upon the attainment of certain performance goals set forth in an award agreement for performance share units granted on February 28, 2023, which will vest on February 28, 2026. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:52 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $85.71 | $85,710.00 |
DisclosureSEC source: 0001776865-26-000002 · wk-form4_1767649970.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,592 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 13:36 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantOptions · Derivative | 24,633 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001878313-26-000008 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,633 Underlying: Common Stock · 24,633 shares Expires 2035-12-31 F1 · derivative.exercise_date: The stock options, granted on December 31, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 13:16 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | PurchaseStock Options · Derivative | 40,849 | $1.36 Strike: $1.36 | $55,554.64 |
DisclosureSEC source: 0001878313-25-000071 · form4.xml · derivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,849 Underlying: Common Stock · 40,849 shares Expires 2028-12-22 F2 · shares: These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the six month anniversary of the issuance date and expire 3-years after the initial issuance date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 13:16 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | PurchaseCommon Stock | 40,849 | $1.22 | $49,999.18 |
DisclosureSEC source: 0001878313-25-000071 · form4.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,873 F1 · shares: The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 00:22 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $84.04 | $84,040.00 |
DisclosureSEC source: 0001776865-25-000032 · wk-form4_1764721347.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,592 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:42 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $80.47 | $80,470.00 |
DisclosureSEC source: 0001776865-25-000030 · wk-form4_1762292565.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,592 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 20:21 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 20,946 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001878313-25-000027 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,946 Underlying: Common Stock · 20,946 shares Expires 2035-10-02 F1 · derivative.exercise_date: The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 21:39 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $83.19 | $83,190.00 |
DisclosureSEC source: 0001776865-25-000028 · wk-form4_1759527558.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,592 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 02, 2025 Filed Sep 3, 2025 21:25 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $86.12 | $86,120.00 |
DisclosureSEC source: 0001776865-25-000026 · wk-form4_1756934730.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,592 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 28, 2025 Filed Aug 29, 2025 20:29 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 5,151 | $88.67 | $456,739.17 |
DisclosureSEC source: 0001776865-25-000024 · wk-form4_1756499377.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,592 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 28, 2023 and February 28, 2024. Read SEC document |
| August 25, 2025 Filed Aug 26, 2025 23:29 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 1,650 | $89.46 | $147,609.00 |
DisclosureSEC source: 0001776865-25-000022 · wk-form4_1756250948.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,743 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 25, 2022. Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 21:51 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $91.21 | $91,210.00 |
DisclosureSEC source: 0001776865-25-000020 · wk-form4_1754949075.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,393 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 21:15 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $87.14 | $87,140.00 |
DisclosureSEC source: 0001776865-25-000017 · wk-form4_1751490937.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,393 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:16 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 20,865 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001127602-25-018656 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,865 Underlying: Common Stock · 20,865 shares Expires 2035-06-30 F1 · derivative.exercise_date: The stock options, granted on June 30, 2025 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 21:31 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $84.91 | $84,910.00 |
DisclosureSEC source: 0001776865-25-000015 · wk-form4_1748986248.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,393 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 01, 2025 Filed May 2, 2025 20:29 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $82.96 | $82,960.00 |
DisclosureSEC source: 0001776865-25-000012 · wk-form4_1746217755.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,393 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 04, 2025 Filed Apr 8, 2025 20:47 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 20,667 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001127602-25-011817 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,667 Underlying: Common Stock · 20,667 shares Expires 2035-04-04 F1 · derivative.exercise_date: The stock options, granted on April 4, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 22:37 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $83.31 | $83,310.00 |
DisclosureSEC source: 0001776865-25-000010 · wk-form4_1743719836.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,393 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:53 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $91.98 | $91,980.00 |
DisclosureSEC source: 0001776865-25-000008 · wk-form4_1741132414.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,393 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 23:53 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 19,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-25-000008 · wk-form4_1741132414.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,393 F1 · kind: Represents a grant of restricted stock units that vest ratably as follows: 33% on August 28, 2026; 33% on August 28, 2027; and 34% on August 28, 2028. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 00:15 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 1,502 | $95.47 | $143,395.94 |
DisclosureSEC source: 0001776865-25-000006 · wk-form4_1740615304.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,297 F2 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of performance share units granted on February 25, 2022. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 00:15 UTC | TransUnion TRU · Entity 2287 | GrantCommon Stock | 3,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-25-000006 · wk-form4_1740615304.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,799 F1 · kind: Reflects shares of Common Stock earned upon the vesting of performance share units granted on February 25, 2022. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 01:17 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $95.95 | $95,950.00 |
DisclosureSEC source: 0001776865-25-000004 · wk-form4_1738718249.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,488 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 23:52 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $93.60 | $93,600.00 |
DisclosureSEC source: 0001776865-25-000002 · wk-form4_1735948350.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,488 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:07 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 10,225 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001127602-25-000383 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,225 Underlying: Common Stock · 10,225 shares Expires 2034-12-31 F1 · derivative.exercise_date: The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 22:24 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,500 | $100.73 | $151,095.00 |
DisclosureSEC source: 0001776865-24-000026 · wk-form4_1733351083.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,488 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 13:56 UTC | TransUnion TRU · Entity 2287 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001776865-24-000024 · wk-form4_1731419807.xml · nonDerivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,988 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 13:56 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,500 | $105.66 | $158,490.00 |
DisclosureSEC source: 0001776865-24-000024 · wk-form4_1731419807.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,988 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:38 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | PurchaseWarrants · Derivative | 22,133 | $2.26 Strike: $2.26 | $49,998.45 |
DisclosureSEC source: 0001127602-24-026383 · form4.xml · derivative · entry 2 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,133 Underlying: Common Stock · 22,133 shares Expires 2030-05-01 F2 · derivative.exercise_date: These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:38 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | PurchaseCommon Stock | 22,133 | $2.51 | $55,553.83 |
DisclosureSEC source: 0001127602-24-026383 · form4.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,024 F1 · shares: The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:55 UTC | MAIA Biotechnology, Inc. MAIA · Entity 6919 | GrantStock Options · Derivative | 7,232 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001127602-24-024955 · form4.xml · derivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,232 Underlying: Common Stock · 7,232 shares Expires 2034-09-30 F1 · derivative.exercise_date: The stock options, granted on September 30, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of thate date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:07 UTC | TransUnion TRU · Entity 2287 | SaleCommon Stock | 1,000 | $95.65 | $95,650.00 |
DisclosureSEC source: 0001776865-24-000022 · wk-form4_1725574016.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,488 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 20:45 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 2,458 | $95.26 | $234,149.08 |
DisclosureSEC source: 0001776865-24-000020 · wk-form4_1725050747.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,488 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 28, 2023. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 20:50 UTC | TransUnion TRU · Entity 2287 | Tax withholdingCommon Stock | 1,601 | $97.28 | $155,745.28 |
DisclosureSEC source: 0001776865-24-000018 · wk-form4_1724791826.xml · nonDerivative · entry 1 CHAOUKI STEVEN M · CIK 0001776865 · President, US Markets 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,946 F1 · kind: Reflects shares of Common Stock withheld by the Company in payment of tax liability incident to the vesting of restricted stock units granted on February 25, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.